In Brief: Hemodialysis component guidance
This article was originally published in The Gray Sheet
Executive Summary
Hemodialysis component guidance: FDA issues final guidance on 510(k)s for hemodialysis water purification components and systems May 30 which incorporates minor clarifications and some additional specifics on data requirements. An initial draft of the document issued in April 1995; a second draft issued in May 1996 ("The Gray Sheet" Oct. 30, 1995, I&W-6). While the guidance is now final, "comments and suggestions may be submitted at any time for agency consideration," the document states...
You may also be interested in...
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.
Beauty Firms Using AI-Based Tools Could Be Subject To Health Privacy Laws In US States
Using AI-based programs to collect and store consumer information risks running afoul of new health privacy laws cropping up in US states. Lack of federal regulation or guidance on the issue is one of the biggest challenges for beauty firms deploying AI, according to Stacy Marcus, partner at Reed Smith LLP.